Associated Papers
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells.
Berlak M et al.
Molecular Cancer, 2022
35689207 (PubMed )
Supplement: 12943_2022_1583_MOESM1_ESM.pdf
Select a paper to view details